1Swerdlow SH, Campo E, Harris NL, et al. World Health Organization(WHO) classification of tumors pathology and genetics of tumors of haematopoietie and lymphoid tissues [ M ]. 4th ed. Lyon : IARC press, 2008 : 14-318.
2Schmidt J, Federmann B, Schindler N, et al. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. [ J] Br J Haematol, 2015,169 (6) :795-803.
3Zini G, Bain B, Bettelheim P, et al. A European consensus report on blood cell identification: terminology utilized and morphological diag- nosis concordance among 28 experts from 17 countries within the Eu-ropean LeukemiaNet network WP10, on behalf of the ELN Morpholo- gy Faculty[J]. Br J Haematol, 2010, 151(4) : 359-364.
